(Q36050719)

11 August 2017

1 reference

title

Throwing new light on lung cancer pathogenesis: updates on three recent topics (English)

1 reference

11 August 2017

1 reference

2

Yasushi Yatabe

1 reference

11 August 2017

Shuta Tomida

1

1 reference

11 August 2017

Kiyoshi Yanagisawa

series ordinal

3

1 reference

11 August 2017

Tetsuya Mitsudomi

series ordinal

4

1 reference

11 August 2017

Takashi Takahashi

series ordinal

5

1 reference

11 August 2017

1 February 2005

1 reference

11 August 2017

1 reference

11 August 2017

96

1 reference

11 August 2017

63-68

1 reference

11 August 2017

2

1 reference

Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells

11 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Lung cancer: an ever increasing store of in-depth basic knowledge and the beginning of its clinical application

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Chromosomal imbalances in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Persistent increase in chromosome instability in lung cancer: possible indirect involvement of p53 inactivation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

MAD2 haplo-insufficiency causes premature anaphase and chromosome instability in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Somatic mutation of the hBUB1 mitotic checkpoint gene in primary lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Infrequent mutation of the hBUB1 and hBUBR1 genes in human lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Cell cycle checkpoints: preventing an identity crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

The p53 network in lung carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

14-3-3sigma is a p53-regulated inhibitor of G2/M progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Decreased expression of 14-3-3sigma in neuroendocrine tumors is independent of origin and malignant potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

The human decatenation checkpoint.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

High frequency of mutations of the PIK3CA gene in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

TTF-1 expression in pulmonary adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Diversity of gene expression in adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Integrated classification of lung tumors and cell lines by expression profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Gene expression-based, individualized outcome prediction for surgically treated lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Two prognostically significant subtypes of high-grade lung neuroendocrine tumours independent of small-cell and large-cell neuroendocrine carcinomas identified by gene expression profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Non-Small-Cell Lung Cancer Molecular Signatures Recapitulate Lung Developmental Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

A molecular signature of metastasis in primary solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Proteomic patterns of tumour subsets in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

Serum protein MALDI profiling to distinguish upper aerodigestive tract cancer patients from control subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2005.00021.X

10.1111/J.1349-7006.2005.00021.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference